FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “KIROMIC”, which is offered here for Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; biopharmaceutical preparations in the nature of t-cell allogenic therapies; biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; biological components, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; therapeutic agents for destroying tumor cells and inhibiting tumor growth; human cells for medical and therapeutic use; t-cells for medical and therapeutic use;.
Its status is currently believed to be active. Its class is unavailable. “KIROMIC” is believed to be currently owned by “KIROMIC BIOPHARMA, INC.”
| Owner: |
KIROMIC BIOPHARMA, INC.
Owner Details |
|---|---|
| Description: |
Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use;
|
| Categories: | PHARMACEUTICAL |